Unknown

Dataset Information

Cyanidin 3-glucoside modulated cell cycle progression in liver precancerous lesion, in vivo study.


ABSTRACT:

Background

Cyanidin-3-O-glucoside (cyan) exhibits antioxidant and anticancer properties. The cell cycle proteins and antimitotic drugs might be promising therapeutic targets in hepatocellular carcinoma.

Aim

To investigate the effect of cyan administration on cell cycle in hepatic precancerous lesion (PCL) induced by diethylnitrosamine/2-acetylaminofluorene (DEN/2-AAF) in Wistar rats.

Methods

In vivo, DEN/2-AAF-induced hepatic PCL, rats were treated with three doses of cyan (10, 15, and 20 mg/kg/d, for four consecutive days per week for 16 wk). Blood and liver tissue samples were collected for measurement of the followings; alpha fetoprotein (AFP) liver function and RNA panel differential expression was evaluated via real time polymerase chain reac

SUBMITTER: Matboli M 

PROVIDER: S-EPMC8047539 | biostudies-literature | 2021 Apr

REPOSITORIES: biostudies-literature